Literature DB >> 19365656

Comparison of vascular complications between conventional treatment and bone marrow transplantation for children with beta-thalassemia disease.

Alisa Limsuwan1, Darin Tubtom, Samart Pakakasama, Ampiwan Chaunsumrit.   

Abstract

Patients with ss-thalassemia may be predisposed to premature atherosclerosis due to vascular dysfunction. This is observed in adults. Whether atherosclerosis changes in ss-thalassemia disease (BTD) occur early in childhood is not clear. To prevent cardiovascular complications, this needs evaluation. Moreover, it remains uncertain whether curative treatment with bone marrow transplantation (BMT) would improve this vascular alteration. For this study, 37 ss-thalassemia children age 10.1 +/- 2.7 years were classified into group 1 (25 children with BTD treated conventionally) and group 2 (12 children with BTD who underwent BMT). A control group of 29 age-matched healthy children were studied simultaneously. The carotid stiffness index and intima-media thickness (IMT) were measured. Group1 had a greater arterial stiffness index than the control subjects (4.57 +/- 1.78 vs. 2.87 +/- 1.07; p < 0.001). The carotid IMT was significantly greater in both BTD groups than in the control group (group 1: 0.45 +/- 0.03 vs. 0.34 +/- 0.04 mm; p < 0.001; group 2: 0.43 +/- 0.03 vs. 0.34 +/- 0.04 mm; p < 0.001). Carotid IMT and arterial stiffness are increased in conventionally treated children with ss-thalassemia, suggesting an early atherosclerotic change in these children, whereas children with BTD who underwent BMT had an increased carotid IMT but normal arterial stiffness.

Entities:  

Mesh:

Year:  2009        PMID: 19365656     DOI: 10.1007/s00246-009-9436-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  24 in total

1.  Arterial stiffness and endothelial function in patients with beta-thalassemia major.

Authors:  Y F Cheung; Godfrey C F Chan; S Y Ha
Journal:  Circulation       Date:  2002-11-12       Impact factor: 29.690

Review 2.  Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes.

Authors:  Athanasios Aessopos; Dimitrios Farmakis; Dimitris Loukopoulos
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

Review 3.  Immune status in thalassemia major.

Authors:  A Neri; V Callea; D G D'Ascola; B Martino
Journal:  Haematologica       Date:  1986 Nov-Dec       Impact factor: 9.941

4.  Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells.

Authors:  A Scaccabarozzi; P Arosio; G Weiss; L Valenti; P Dongiovanni; A L Fracanzani; M Mattioli; S Levi; G Fiorelli; S Fargion
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

5.  Reduction of tumour necrosis factor alpha expression and signalling in peripheral blood mononuclear cells from patients with thalassaemia or sickle cell anaemia upon treatment with desferrioxamine.

Authors:  A Bellocq; D Israël-Biet; J Cadranel; J Perez; B Fouqueray; A Kanfer; R Girot; L Baud
Journal:  Cytokine       Date:  1999-02       Impact factor: 3.861

6.  Effects of deferiprone on immune status and cytokine pattern in thalassaemia major.

Authors:  Giovanni Carlo Del Vecchio; Federico Schettini; Laura Piacente; Attilio De Santis; Paola Giordano; Domenico De Mattia
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

7.  IL-6 and IL-8 production by human bone marrow stromal cells.

Authors:  F Rougier; E Cornu; V Praloran; Y Denizot
Journal:  Cytokine       Date:  1998-02       Impact factor: 3.861

8.  Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C.

Authors:  D Praticó; M Pasin; O P Barry; A Ghiselli; G Sabatino; L Iuliano; G A FitzGerald; F Violi
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

9.  Global vasomotor dysfunction and accelerated vascular aging in beta-thalassemia major.

Authors:  George Hahalis; Dimitrios T Kremastinos; George Terzis; Andreas P Kalogeropoulos; Athina Chrysanthopoulou; Marina Karakantza; Alexandra Kourakli; Stamatis Adamopoulos; Alexandros D Tselepis; Nikos Grapsas; Dimitrios Siablis; Nicholas C Zoumbos; Dimitrios Alexopoulos
Journal:  Atherosclerosis       Date:  2007-11-07       Impact factor: 5.162

10.  Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status.

Authors:  G Lombardi; R Matera; M M Minervini; N Cascavilla; P D'Arcangelo; M Carotenuto; G Di Giorgio; P Musto
Journal:  Haematologica       Date:  1994 Sep-Oct       Impact factor: 9.941

View more
  1 in total

1.  Circulating CD133(+)VEGFR2 (+) and CD34 (+)VEGFR2 (+) cells and arterial function in patients with beta-thalassaemia major.

Authors:  Yiu-Fai Cheung; Shing Chan; Mo Yang; Jie-Yu Ye; Shau-Yin Ha; Sophia J Wong; Godfrey Chi-Fung Chan
Journal:  Ann Hematol       Date:  2011-08-02       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.